ICU
SeaStar Medical Holding Corporation
NASDAQ: ICU · HEALTHCARE · BIOTECHNOLOGY
$4.14
+6.98% today
Updated 2026-04-30
Market cap
$15.22M
P/E ratio
—
P/S ratio
12.33x
EPS (TTM)
$-5.86
Dividend yield
—
52W range
$2 – $13
Volume
0.2M
SeaStar Medical Holding Corporation (ICU) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $2.91M | $603000.00 | $3.04M | $3.51M | $4.66M |
| Cash & equivalents | $2.81M | $510000.00 | $47000.00 | $176000.00 | $1.82M |
| Current assets | $2.91M | $601000.00 | $1.52M | $2.31M | $3.77M |
| Total liabilities | $74.49M | $3.42M | $23.80M | $17.38M | $6.84M |
| Current liabilities | $1.08M | $3.12M | $16.15M | $13.05M | $6.84M |
| Long-term debt | $63000.00 | $244000.00 | $7.65M | $4.34M | — |
| Shareholder equity | $-71.58M | $-2.82M | $-20.76M | $-13.87M | $-2.18M |
| Retained earnings | $-71.72M | $-76.31M | $-88.50M | $-114.73M | $-139.56M |
| Accounts receivable | $44955.00 | $58000.00 | $12000.00 | $0.00 | $112000.00 |
| Inventory | $55000.00 | $0.00 | — | — | — |
| Goodwill | — | — | — | — | — |